期刊文献+

雌激素对离体成骨细胞成骨能力的影响 被引量:4

Effect of estrogen on the osteogenic ability of osteoblast
下载PDF
导出
摘要 目的 验证不同浓度的雌三醇对人类成骨细胞功能表达和体外成骨能力的影响 ,研究雌激素促进成骨作用的机制及剂量效应关系。方法 取成人的髂骨松质骨 ,采用胶原 胰蛋白酶消化法 ,获得松质骨中的成骨细胞 ,进行纯化和培养。在此基础上添加不同浓度的雌三醇 (1× 10 - 11、1× 10 - 9、1× 10 - 7、1× 10 - 6 、1× 10 - 5 、5× 10 - 5 mol·L- 1)并进行培养。用生化法测定细胞碱性磷酸酶 (ALP)活性 ,用放射免疫法测定细胞培养液中骨钙素 (OC)和细胞间质含钙量。结果 雌三醇对成骨细胞ALP活性和骨钙素分泌的影响均呈正相关 ,即各浓度雌三醇对ALP活性和骨钙素的分泌均有刺激作用 ,并与雌三醇剂量呈正相关。低浓度 (1× 10 - 11、1× 10 - 9、1× 10 - 7mol·L- 1)的雌三醇可促进成骨细胞的成骨能力 ,高浓度时则无此作用。结论 雌激素能增加成骨细胞的ALP活性和骨钙素的产生 。 Objective To verify the effects of different conc entrations of auecifemine on the function of osteoblast cell expression and oste ogenic ability in vitro . Methods Iliac spongy bone specimens were obtained from twel ve adult patients scheduled surgery. After the bone pieces were treated with col lagenase-trypsin, osteoblasts were obtained from cancellous bones. Then the ost eoblasts were purified and cultivated. They were cultured in medium with various concentrations(1×10 -11 , 1×10 -9 , 1×10 -7 , 1×10 -6 , 1 ×10 -5 , 5×10 -5 mol·L -1 ). The alkaline phosphatase (ALP) acti vity, osterocalcin and osteogenic ability were examined by biochemical assay and radioimmunologic assay (RIA), respectively. Results The co rrelation of auecifemine of different concentrations with ALP activity and osteo calcin secretion was positive. Auecifemine of lower concentrations (1×10 -11 mol·L -1 , 1×10 -9 mol·L -1 and 1×10 -7 mol·L -1 ) s howed the stimulating effect on osteogenic ability and but not higher concentrat ion. Conclusion Estrogen can increase osteoblast ALP activi ty, osteocalcin production, and osteogenic ability.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2004年第1期48-50,共3页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 雌激素 成骨细胞 成骨能力 雌三醇 碱性磷酸酶 骨钙素 骨质疏松症 auecifemine osteoblast alkaline phosphatase os teocalcin osteogenic ability
  • 相关文献

参考文献2

二级参考文献11

  • 1张乃峥.类风湿关节炎[A].见:张乃峥主编.临床风湿病学[C].上海:上海科学技术出版社,1999.118—137.
  • 2Roodman GD. Cell biology of the osteoclast. Exp Hematol, 1999,27:1229-1241.
  • 3Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin a novel secreted protein involved in the regulation of bone density. Cell,1997, 89: 309-319.
  • 4Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev, 1998, 12: 1260-1268.
  • 5Morony S, Capparelli C, Lee R, et al. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL1β, TNF-α, PTH, PTHrP, and 1, 25 (OH)2D3. J Bone Miner Res, 1999, 14: 1478-1485.
  • 6Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligandis a cytokine that regulates osteoclast diferentiation and activation. Cell,1998, 93: 165-176.
  • 7Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med, 2000, 191:275-286.
  • 8Jimi E, Nakamura I, Duong LT, et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res, 1999, 247: 84-93.
  • 9Hofbauer LC, Dunstan CR, Spelsberg TC, et al. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun, 1998, 250: 776-781.
  • 10Kakudo S, Miyazawa K, Kameda T, et al. Isolation of highly enriched rabbit osteoclasts from collagen gels a new assay system for bone-resorbing activity of mature osteoclasts. J Bone Miner Metab,1996, 14: 129-136.

共引文献7

同被引文献87

  • 1单春艳,郑少雄,陈莉明,J Y Reginster.绝经后骨质疏松妇女全血细胞分泌某些细胞因子水平的改变[J].中国组织工程研究与临床康复,2001,10(18):104-105. 被引量:7
  • 2田庆显,黄公怡.OPG/RANK/RANKL系统和骨质疏松[J].中华骨科杂志,2004,24(11):683-686. 被引量:11
  • 3丁继华,陈宝兴,赵湘洪.补肾药治疗骨关节病的实验研究[J].中国中医骨伤科杂志,1989,5(3):3-6. 被引量:25
  • 4Joo SS,Kang HC,Lee MW,et al.Inhibition of IL-1beta and IL-6 in osteoblast-like cell by isoflavones extracted from Sophorae fructus[J].Arch Pharm Res,2003,26 (12):1029~1035
  • 5Taranta A,Brama M,Teti A,et al.The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro[J].Bone,2002,30 (2):368~ 376
  • 6Syed F,Khosla S.Mechanisms of sex steroid effects on bone [J].Biochem Biophys Res Commun,2005,328 (3):688~ 696
  • 7Spelsberg TC,Subramaniam M,Riggs BL,et al.The actions and interactions of sex steroids and growth factors/cytokines on the skeleton[J].Mol Endocrinol,1999,13:819~ 828
  • 8Jiang G,Matsumoto H,Fujii A.Mandible bone loss in osteoporosis rats[J].J Bone Miner Metab,2003,21 (6):388~ 395
  • 9Zhou S,Zilberman Y,Wassermann K,et al.Estrogen modulates estrogen receptor alpha and beta expression,osteogenic activity,and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice [J].J Cell Biochem,2001,81(S36):144~ 155
  • 10Kanno S,Hirano S,Kayama F.Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 ceils[J].Toxicology,2004,196 (1-2):137~ 145

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部